Mediators of Inflammation

Clinical Study

Value of C-Reactive Protein in Predicting Left Ventricular Remodelling in Patients with a First ST-Segment Elevation Myocardial Infarction

Table 3

Echocardiographic characteristics of the study population. Echocardiographic indices are derived from 2D, Doppler echocardiography, and tissue Doppler echocardiography at hospital discharge and at 6 month after discharge, respectively.


Variable	Overall study population ()	Patients with LVR ()	Patients without LVR ()	for comparison between groups with and without LVR

Echocardiographic indices at discharge

LA (mm)	39.0 (36.0–42.0)	39.0 (36.0–45.0)	39.0 (36.0–41.0)	NS
LVEDd (mm)	49.0 (45.0–53.0)	49.0 (43.0–53.0)	49.0 (45.0–53.0)	NS
LVESd (mm)	34.0 (30.0–37.0)	34.0 (30.0–38.0)	33.0 (30.0–36.0)	NS
LVMI (g/m²)	114.3 (96.7–132.3)	114.4 (99.0–133.4)	114.1 (96.5–132.3)	NS
LVEDV (mL)	97.0 (82.0–118.0)	95.0 (81.0–118.0)	99.0 (83.0–118.0)	NS
LVEDVI (mL/m²)	50.5 (44.0–60.8)	48.7 (42.0–57.9)	51.4 (45.6–62.1)	NS
LVESV (mL)	53.5 (44.0–68.0)	57.0 (43.0–66.0)	52.0 (44.0–68.0)	NS
LVESVI (mL/m²)	27.7 (23.1–35.0)	26.9 (23.0–34.1)	27.7 (23.2–35.7)	NS
LVEF (%)	44.8 (40.0–49.4)	43.0 (38.5–48.0)	45.0 (40.4–49.9)	NS
WMSI (pts)	1.5 (1.38–1.75)	1.63 (1.38–1.75)	1.5 (1.38–1.75)	NS
S′ (cm/s)	7.01 (6.14–8.15)	6.75 (5.98–7.9)	7.15 (6.3–8.15)	NS
/	0.84 (0.66–1.09)	0.85 (0.68–1.12)	0.82 (0.64–1.06)	<0.05
DT (ms)	155.0 (145.0–185.0)	150.0 (140.0–170.0)	160.0 (150.0–190.0)	<0.001
/	9.6 (7.3–11.8)	9.9 (5.3–20.6)	9.5 (7.3–11.5)	NS

Echocardiographic indices at 6 month after discharge

LA (mm)	40.0 (37.0–44.0)	42.0 (38.0–46.0)	40.0 (37.0–43.0)	<0.05
LVEDd (mm)	50.0 (46.0–54.0)	53.0 (47.0–56.0)	49.0 (46.0–53.0)	<0.01
LVESd (mm)	34.0 (31.0–37.0)	36.0 (32.0–40.0)	33.0 (31.0–36.0)	<0.01
LVMI (g/m²)	115.3 (102.7–134.8)	124.5 (108.3–143.0)	112.1 (98.9–130.3)	<0.01
LVEDV (mL)	110.0 (91.0–133.0)	128.0 (110.0–154.0)	100.0 (88.0–126.0)	<0.001
LVEDVI (mL/m²)	57.2 (48.8–68.3)	66.6 (55.2–86.0)	54.0 (46.5–65.3)	<0.001
LVESV (mL)	57.0 (46.0–74.0)	72.0 (55.5–94.0)	51.2 (43.0–68.0)	<0.001
LVESVI (mL/m²)	29.2 (24.8–38.9)	35.3 (27.8–46.1)	27.7 (23.5–35.9)	<0.001
LVEF (%)	46.0 (42.3–52.0)	44.0 (38.0–49.0)	46.6 (43.0–52.0)	<0.01
WMSI (pts)	1.44 (1.31–1.63)	1.5 (1.38–1.75)	1.44 (1.31–1.63)	<0.01
S′ (cm/s)	6.98 (6.13–8.13)	6.5 (5.55–7.58)	7.08 (6.23–8.28)	<0.01
/	0.85 (0.67–1.12)	0.89 (0.75–1.37)	0.82 (0.64–1.06)	<0.01
DT (ms)	170.0 (155.0–195.0)	160.0 (150.0–185.0)	179.0 (155.0–200.0)	<0.05
/	8.9 (7.5–11.1)	9.7 (5.7–22.4)	8.7 (7.2–10.1)	<0.05

DT: Deceleration time of early transmitral flow; : peak velocity of early transmitral flow; : peak velocity of transmitral flow during atrial systole; : average peak early diastolic mitral annular velocity; LA: left atrium; LVEDd: left ventricular end-diastolic diameter; LVEDV: left ventricular end-diastolic volume; LVEDVI: left ventricular end-diastolic volume index; LVEF: left ventricular ejection fraction; LVESd: left ventricular end-systolic diameter; LVESV: left ventricular end-systolic volume; LVESVI: left ventricular end-systolic volume index; LVMI: left ventricle mass index; LVR: left ventricular remodelling; : average peak systolic mitral annular velocity; WMSI: wall motion score index.